SNSE- Sensei Biotherapeutics, Inc.

Insider activity in SNSE over the last quarter tilts toward selling: insiders offloaded a net 34,359 shares worth roughly $600K.

Classified under Biotechnology (Health Care sector), SNSE's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
COO	Parikh Anand Kiran	1.24M	-	-
Pres	Gerry Christopher	220.0K	-	-
10%	Peyer James	130.6K	$2.61M	-
10%	Cambrian Biopharma Inc	130.6K	$2.61M	-
Other	Craver Josiah	80.0K	-	-

Buys and sells only

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 24, 2022	Cambrian Biopharma Inc	10% Owner	Buy	47,410	$4.82	$228,528.65	+0.5%	-63.1%	-71.6%
Jan 24, 2022	Peyer James	Director, 10% Owner	Buy	47,410	$4.82	$228,528.65	+0.5%	-63.1%	-71.6%
Jan 20, 2022	Peyer James	Director, 10% Owner	Buy	30,244	$5.10	$154,312.68	+0.3%	-62.2%	-70.1%
Jan 20, 2022	Cambrian Biopharma Inc	10% Owner	Buy	30,244	$5.10	$154,312.68	+0.3%	-62.2%	-70.1%
Jan 18, 2022	Peyer James	Director, 10% Owner	Buy	10,000	$5.08	$50,800.00	+0.2%	-63.1%	-72.0%
Jan 18, 2022	Cambrian Biopharma Inc	10% Owner	Buy	10,000	$5.08	$50,800.00	+0.2%	-63.1%	-72.0%
Jan 14, 2022	Cambrian Biopharma Inc	10% Owner	Buy	26,172	$5.10	$133,391.70	+0.3%	-63.4%	-70.0%
Jan 14, 2022	Peyer James	Director, 10% Owner	Buy	26,172	$5.10	$133,391.70	+0.3%	-63.4%	-70.0%
Jan 12, 2022	Cambrian Biopharma Inc	10% Owner	Buy	20,047	$5.20	$104,211.54	+0.2%	-60.8%	-70.9%
Jan 12, 2022	Peyer James	Director, 10% Owner	Buy	20,047	$5.20	$104,211.54	+0.2%	-60.8%	-70.9%